MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    The PD-Ballet study: a randomised controlled, single-blinded trial of dance therapy for Parkinson’s, baseline characteristics of the study cohort

    A. Podlewska, L. Batzu, J. Staunton, P. Tall, V. Leta, M. Uribe Mz-Recaman, F. Derbyshire-Fox, A. Hartley, T. Soukup, R. Davis, N. Sevdalis, A. Healey, I. Bakolis, C. Pariante, A. Woods, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To describe baseline characteristics of the cohort of participants recruited to a world-first randomised controlled single blind trial of ballet-based dance intervention for holistic…
  • 2023 International Congress

    Modulation of autophagy and neuroinflammation by Niclosamide in MPTP Induced- Parkinson’s disease model

    SHI. Kartik (Lucknow, India)

    Objective: The current investigation aimed to investigate the neuroprotective effect of niclosamide (NI) on autophagy and neuroinflammatory pathways in Parkinson’s disease (PD). Background: Autophagy dysregulation…
  • 2023 International Congress

    Use of insect model to study Parkinson’s disease pathophysiology by inducing GSH-depletion and behavioral deficits among larvae: Evidences of ameliorative properties of phytoconstituents

    G. Chandran, R. D'Silva, M. Muralidhara (MYSURU, India)

    Objective: The purpose of the study is to establish an all-around model for Parkinson's disease using Drosophila melanogaster, the fruit-fly in order to understand  behavioral…
  • 2023 International Congress

    Posturography as an objective measure of disease progression and prognostication in Progressive Supranuclear Palsy

    G. Nuebling, S. Katzdobler, J. Levin, G. Höglinger, S. Lorenzl (Munich, Germany)

    Objective: To determine the usefulness of posturography as an objective measure of disease progression and prognostication on Progressive Supranuclear Palsy (PSP). Background: To date, interventional…
  • 2023 International Congress

    The prevalence and clinical features of GBA-related Parkinson’s disease in a Slovak patient cohort

    A. Lackova, J. Necpal, V. Han, P. Pavelekova, K. Kulcsarova, T. Svorenova, L. Baranova, E. Tusay, B. Kovacova, E. Petro, B. Stasko, K. Burasova, M. Ostrozovicova, S. Bohacova, Z. Gdovinova, M. Skorvanek (Kosice, Slovakia)

    Objective: The aim of our study was to determine the prevalence and clinical characteristics of Slovak GBA-related patients with Parkinson's disease (PwP). Background: GBA variants…
  • 2023 International Congress

    Drug-induced Parkinsonism and nonmotor symptoms: a case of gustatory rhinorrhea

    S. Casanova, A. Cabral, M. Branco (Vila Nova Gaia, Portugal)

    Objective: We aim to emphasize the relevance of contemplating nonmotor symptoms as possible features of drug-induced parkinsonism, and the utmost importance of further investigation in…
  • 2023 International Congress

    Investigate the association of MAPT haplotype and neuroanatomical structure and its influence on the risk of Parkinson’s disease

    E. Yu, C. Tremblay, A. Vo, Y. Sosero, Z. Gan-Or, A. Dagher, L. Liu ()

    Objective: To investigate if the vulnerability of Parkinson’s Disease (PD) can be reflected in the neuroanatomical structure in different MAPT haplotype carriers. Background: It has…
  • 2023 International Congress

    Bowel symptoms and management practices in Parkinson’s disease and related conditions: results from the PRIME-UK study.

    C. Thomas, E. Tenison, K. Lloyd, M. Smith, Y. Ben-Shlomo, E. Henderson (Gloucestershire, United Kingdom)

    Objective: To describe bowel symptoms and constipation management practices in a large, representative cross-sectional study of Parkinson’s and related disorders. Background: Bowel symptoms, particularly constipation,…
  • 2023 International Congress

    A digital differential diagnostic aid for Parkinson’s disease and other tremor disorders

    C. Papasavvas, D. Bramwell, R. Zietsma, A. Deutschlander, R. Walker (Edinburgh, United Kingdom)

    Objective: To validate an AI-enhanced decision support tool to assist health care professionals (HCP) in distinguishing between patients with Parkinson’s disease (PD) and those with…
  • 2023 International Congress

    Characterization of gait variability of early Parkinson’s disease and multiple system atrophy

    M. Jecmenica Lukic, A. Tomic, I. Stankovic, V. Markovic, N. Kresojevic, N. Dragasevic, M. Svetel, I. Petrovic, S. Radovanovic, V. Kostic (Belgrade, Serbia)

    Objective: to determine the potential differences in gait characteristics between PD-GBA carriers and non-carriers (idiopathic Parkinson’s disease (iPD)), both mutually and in relation to MSA-P.…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley